P-2059. Perceptions and Factors Associated with Uptake of Monovalent XBB.1.5 BNT162b2 COVID-19 Vaccine among Healthcare Workers in Peru

Abstract Background The implementation of the XBB.1.5 BNT162b2 COVID-19 vaccine (updated vaccine) occurred in Peru in January 2024, since then, many questions about its efficacy and safety have been raised. Addressing these concerns is crucial, especially among healthcare workers, given their high r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gonzales-Zamora, Jose A, Araoz-Salinas, Julieta M, Quispe‐Vicuña, Carlos, Reátegui García, Martín Ernesto, Ortiz-Saavedra, Brando, Soriano Moreno, Anderson Nelver Elías, Baltazar-Ñahui, Hans, Alave Rosas, Jorge Luis
Formato: Artículo
Lenguaje:inglés
Publicado: 2025
Acceso en línea:Enlace permanente (DOI o Handle)
Enlace permanente (DOI o Handle)
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares: P-2059. Perceptions and Factors Associated with Uptake of Monovalent XBB.1.5 BNT162b2 COVID-19 Vaccine among Healthcare Workers in Peru